The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Open accessAbstract
Clustered, regularly interspaced, short palindromic repeat (CRISPR) RNA-guided nucleases (RGNs) have rapidly emerged as a facile and efficient platform for genome editing. Here, we use a human cell-based reporter assay to characterize off-target cleavage of CRISPR-associated (Cas)9-based RGNs. We find that single and double mismatches are tolerated to varying degrees depending on their position along the guide RNA (gRNA)-DNA interface. We also readily detected off-target alterations induced by four out of six RGNs targeted to endogenous loci in human cells by examination of partially mismatched sites. The off-target sites we identified harbored up to five mismatches and many were mutagenized with frequencies comparable to (or higher than) those observed at the intended on-target site. Our work demonstrates that RGNs can be highly active even with imperfectly matched RNA-DNA interfaces in human cells, a finding that might confound their use in research and therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, in-depth studies on the outcomes of Cas9-induced double-strand break (DSB) repair have shown significant off-target effects, which resulted in substitution, insertion, deletion, and DNA translocation.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Defective off-target binding and cleaving can result in collateral mutagenesis induced by the error-prone repair of DSB by NHEJ [106,107].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [107]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For example, a study demonstrated that manipulating Cas9's biophysical attributes, such as minimizing nonspecific RNA-DNA interactions, significantly reduces off-target mutations while maintaining high on-target efficiency.”
From Hybrid Neural Networks for Off-Target Prediction in Gene Editing: Integrating Sequence and Biophysical Features (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“A study reported highfrequency off-target mutagenesis in transduced human cell lines after SpCas9 delivery [108].”
From Immune responses to gene editing by viral and non-viral delivery vectors used in retinal gene therapy (2022) · cites this paper as [108]
In the citing paper
“Using a VEGFA sgRNA with well-characterized off-target sites24, we observed that transient Cas9 expression by mRNA delivery can substantially reduce off-target genome editing in cells (Fig. 1f–h).”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [24]
In the citing paper
“as mentioned in several recent publications, Cas9 tolerates mismatches between the guide RNA and target DNA in a sequence-dependent manner and potentially tolerates up to five target mismatches in human cells [12], [24], [25], [26], [27], thereby promoting undesired off-target mutations.”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [24]
In the citing paper
“non-specific cleavage may occur in the cellular genome [12], [24], [25], [26], [27].”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [24]
In the citing paper
“Because the sequence specificity of Streptococcus pyogenes Cas9 tolerates 4 mismatches between the gRNA and complementary sequence”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [24]
In the citing paper
“Collectively, these studies indicate that although each base within the 20 nt guide sequence contributes to overall specificity”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [90]
In the citing paper
“However, it has been recently shown that CRISPR/Cas9 system can be highly active even when mismatches occur between gRNA and their DNA targets”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [90]
In the citing paper
“multiple mismatches between the guide RNA and its complementary target DNA sequence can be tolerated depending on the quantity, position, and base identity of mismatches [87,90,91,93], all of which contribute to potential off-target activity.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [90]
In the citing paper
“and off-target mutations occur at endogenous loci in human cells with high frequency [90,91,92].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,023
CRISPR–Cas system: a powerful tool for genome engineering
Liu, L., & Fan, X.-D. (2014) · Plant Molecular Biology · doi:10.1007/s11103-014-0188-7 · Cited by 73
RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
Gasiūnas, G., & Šikšnys, V. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.09.001 · Cited by 70
Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases
Mock, U., Riecken, K., Berdien, B., Qasim, W., Chan, E., Cathomen, T., & Fehse, B. (2014) · Scientific Reports · doi:10.1038/srep06409 · Cited by 68
Jaskula-Ranga, V., Wahlin, K. J., Maruotti, J., & Zack, D. J. (2014) · Nature Communications · doi:10.1038/ncomms5516 · Cited by 74
Genetic and Genomic Tools for the Marine AnnelidPlatynereis dumerilii
Zantke, J., Bannister, S. C., Rajan, V. B. V., Raible, F., & Tessmar‐Raible, K. (2014) · Genetics · doi:10.1534/genetics.112.148254 · Cited by 72
Treating Cystic Fibrosis with mRNA and CRISPR
Sanchez, A. D. S., Paunovska, K., Cristian, A., & Dahlman, J. E. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.137 · Cited by 75
Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation
Rao, S., Yao, Y., & Bauer, D. E. (2021) · Genome Medicine · doi:10.1186/s13073-021-00857-3 · Cited by 72
Cavazza, A., Molina-Estévez, F. J., Reyes, Á. P., Ronco-Díaz, V., Naseem, A., Malenšek, Š., Pečan, P., Santini, A., Heredia, P., Aguilar-González, A., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102457 · Cited by 78
Efficient genomic correction methods in human iPS cells using CRISPR–Cas9 system
Li, H. L., Gee, P., Ishida, K., & Hotta, A. (2016) · Methods · doi:10.1016/j.ymeth.2015.10.015 · Cited by 62
Fine-Tuning Next-Generation Genome Editing Tools
Kanchiswamy, C. N., Maffei, M. E., Malnoy, M., Velasco, R., & Kim, J. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.03.007 · Cited by 70
Onyido, E. K., Sweeney, E., & Nateri, A. S. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0541-3 · Cited by 69
Controlling microbial PHB synthesis via CRISPRi
Li, D., Lv, L., Chen, J., & Chen, G. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8374-6 · Cited by 69
Honda, A., Hirose, M., Sankai, T., Yasmin, L., Yuzawa, K., Honsho, K., Izu, H., Iguchi, A., Ikawa, M., & Ogura, A. (2014) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.14-0034 · Cited by 67
Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA
Zhang, Y., Ling, X., Su, X., Zhang, S., 王, J. 璟. W., Zhang, P., Feng, W., Zhu, Y. Y., Liu, T., & Tang, X. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202009890 · Cited by 67
Simkin, D., Papakis, V., Bustos, B. I., Ambrosi, C. M., Ryan, S. J., Baru, V., Williams, L. A., Dempsey, G. T., McManus, O. B., Landers, J. E., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.02.008 · Cited by 68
From pharmacogenetics to pharmaco-omics: Milestones and future directions
Auwerx, C., Sadler, M. C., Reymond, A., & Kutalik, Z. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100100 · Cited by 72
Távora, F. T. P. K., Diniz, F. D. A. D. S., Rêgo-Machado, C. M., Freitas, N. C., Arraes, F. B. M., de Andrade, E. C., Furtado, L. L., Osiro, K. O., de Sousa, N. L., Cardoso, T. B., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.913728 · Cited by 73
Cardiac xenotransplantation: from concept to clinic
Reichart, B., Cooper, D., Längin, M., Tonjes, R., Pierson, R., & Wolf, E. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac180 · Cited by 56
Resources for Functional Genomics Studies in Drosophila melanogaster
Mohr, S. E., Hu, Y., Kim, K., Housden, B. E., & Perrimon, N. (2014) · Genetics · doi:10.1534/genetics.113.154344 · Cited by 70
CRISPR/Cas9-mediated GJA8 knockout in rabbits recapitulates human congenital cataracts
Yuan, L., Sui, T., Chen, M., Deng, J., Huang, Y., Zeng, J., Lv, Q., Song, Y., Li, Z., & Lai, L. (2016) · Scientific Reports · doi:10.1038/srep22024 · Cited by 67
Tan, Z., Jiang, Y., Ganewatta, M. S., Kumar, R., Keith, A. R., Twaroski, K., Pengo, T., Tolar, J., Lodge, T. P., & Reineke, T. M. (2019) · Macromolecules · doi:10.1021/acs.macromol.9b01645 · Cited by 69
Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials
Esensten, J. H., Bluestone, J. A., & Lim, W. A. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100304 · Cited by 62
New considerations for hiPSC-based models of neuropsychiatric disorders
Hoffman, G. E., Schrode, N., Flaherty, E. K., & Brennand, K. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0029-1 · Cited by 71
Genome Editing in Mice Using CRISPR/Cas9 Technology
Hall, B., Cho, A., Limaye, A., Cho, K., Khillan, J. S., & Kulkarni, A. B. (2018) · Current Protocols in Cell Biology · doi:10.1002/cpcb.57 · Cited by 72
Yoon, H. H., Ye, S., Lim, S., Jo, A., Lee, H., Hong, F., Lee, S. E., Oh, S., Kim, N., Kim, K., et al. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0025 · Cited by 68
Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing
Zheng, Z., Guo, L., Cui, C., Wang, F., Wang, X., Xu, Z., Guo, H., Chen, Y., Wang, D., Wang, D., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00893-4 · Cited by 68
Hoberecht, L., Perampalam, P., Lun, A. T. L., & Fortin, J. (2022) · Nature Communications · doi:10.1038/s41467-022-34320-7 · Cited by 66
Efficient generation of genome-modified mice via offset-nicking by CRISPR/Cas system
Fujii, W., Onuma, A., Sugiura, K., & Naito, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.141 · Cited by 66
Landscape of target:guide homology effects on Cas9-mediated cleavage
Fu, B. X. H., Hansen, L. L., Artiles, K. L., Nonet, M. L., & Fire, A. Z. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1102 · Cited by 66
A morphospace for synthetic organs and organoids: the possible and the actual
Ollé-Vila, A., Duran‐Nebreda, S., Pueyo, N. C., Montañez, R., & Solé, R. V. (2016) · Integrative Biology · doi:10.1039/c5ib00324e · Cited by 66
Jin, C., Fotaki, G., Ramachandran, M., Nilsson, B., Essand, M., & Yu, D. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505869 · Cited by 66
Organoid technologies meet genome engineering
Nie, J., & Hashino, E. (2017) · EMBO Reports · doi:10.15252/embr.201643732 · Cited by 69
A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies
McHugh, D. R., Steele, M., Valerio, D. M., Miron, A., Mann, R. J., LePage, D. F., Conlon, R. A., Cotton, C. U., Drumm, M. L., & Hodges, C. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199573 · Cited by 69
Stem cells for investigation and treatment of inherited retinal disease
Tucker, B. A., Mullins, R. F., & Stone, E. M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu124 · Cited by 65
CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges
Demirci, S., Leonard, A., Haro-Mora, J. J., Uchida, N., & Tisdale, J. F. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2018_331 · Cited by 50
Lysosomal storage diseases: current therapies and future alternatives
Leal, A. F., Espejo-Mojica, A. J., Sánchez, O. F., Ramírez, C. M., Reyes, L. H., Cruz, J. C., & Alméciga-Díaz, C. J. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01935-6 · Cited by 66
Genome editing in cardiovascular diseases
Mani, I. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.021 · Cited by 66
Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
Huang, X., Yang, D., Zhang, J., Xu, J., & Chen, Y. E. (2022) · Cells · doi:10.3390/cells11142186 · Cited by 68
Xu, W., Zhang, S., Qin, H., & Yao, K. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05957-3 · Cited by 74
The iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem Cells
Zhu, Z., González, F., & Huangfu, D. (2014) · Methods in Enzymology · doi:10.1016/b978-0-12-801185-0.00011-8 · Cited by 66
Nuclease‐mediated genome editing: At the front‐line of functional genomics technology
Sakuma, T., & Woltjen, K. (2014) · Development Growth & Differentiation · doi:10.1111/dgd.12111 · Cited by 70
CRISPR-Cas9-Based Knockout of the Prion Protein and Its Effect on the Proteome
Mehrabian, M., Dylan, B., MacIsaac, S., Kim, J. K., Gunawardana, C. G., Wang, H., & Schmitt‐Ulms, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114594 · Cited by 64
A versatile reporter system for CRISPR-mediated chromosomal rearrangements
Li, Y., Park, A. I., Mou, H., Colpan, C., Bizhanova, A., Akama‐Garren, E. H., Joshi, N., Hendrickson, E. A., Feldser, D. M., Yin, H., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0680-7 · Cited by 64
Unified energetics analysis unravels SpCas9 cleavage activity for optimal gRNA design
Zhang, D., Hurst, T., Duan, D., & Chen, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820523116 · Cited by 63
Generation of targeted mouse mutants by embryo microinjection of TALEN mRNA
Wefers, B., Panda, S. K., Ortiz, O., Brandl, C., Hensler, S., Hansen, J., Wurst, W., & Kühn, R. (2013) · Nature Protocols · doi:10.1038/nprot.2013.142 · Cited by 58
Cas9 cleavage assay for pre-screening of sgRNAs using nicking triggered isothermal amplification
Zhang, K., Deng, R., Li, Y., Zhang, L., & Li, J. (2016) · Chemical Science · doi:10.1039/c6sc01355d · Cited by 64
Applying CRISPR–Cas9 tools to identify and characterize transcriptional enhancers
Lopes, R., Korkmaz, G., & Agami, R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.79 · Cited by 65
CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Rahman, M. U., Bilal, M., Shah, J. A., Kaushik, A. K., Teissèdre, P., & Kujawska, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061252 · Cited by 65
Transcriptional Activation of Biosynthetic Gene Clusters in Filamentous Fungi
Mózsik, L., Iacovelli, R., Bovenberg, R. A. L., & Driessen, A. J. M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.901037 · Cited by 68
A CRISPR-Cas Cure for HIV/AIDS
Hussein, M., Molina, M. A., Berkhout, B., & Herrera-Carrillo, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021563 · Cited by 70
Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets
Niu, X., Zhang, L., Wu, Y., Zong, Z., Wang, B., Liu, J., Zhang, L., & Zhou, F. (2023) · MedComm · doi:10.1002/mco2.223 · Cited by 73
Application of CRISPR/Cas9 genome editing to the study and treatment of disease
Pellagatti, A., Dolatshad, H., Valletta, S., & Boultwood, J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1504-y · Cited by 65
Designed nucleases for targeted genome editing
Lee, J., Chung, J., Kim, H. M., Kim, S., & Kim, S. (2015) · Plant Biotechnology Journal · doi:10.1111/pbi.12465 · Cited by 70
The genome editing revolution: A CRISPR‐Cas TALE off‐target story
Stella, S., & Montoya, G. (2016) · BioEssays · doi:10.1002/bies.201670903 · Cited by 66
Use of gene-editing technology to introduce targeted modifications in pigs
Ryu, J., Prather, R. S., & Lee, K. (2018) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-017-0228-7 · Cited by 65
Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy
Wang, L., Zheng, W., Liu, S., Li, B. J., & Jiang, X. (2018) · ChemBioChem · doi:10.1002/cbic.201800629 · Cited by 66
Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing
Li, J., Hong, S., Chen, W., Zuo, E., & Yang, H. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.002 · Cited by 66
Precision genetic modifications: a new era in molecular biology and crop improvement
Fichtner, F., Urrea-Castellanos, R., & Ülker, B. (2014) · Planta · doi:10.1007/s00425-014-2029-y · Cited by 67
Versatile single-step-assembly CRISPR/Cas9 vectors for dual gRNA expression
Adikusuma, F., Pfitzner, C., & Thomas, P. Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187236 · Cited by 58
Taemaitree, L., Shivalingam, A., El-Sagheer, A. H., & Brown, T. P. (2019) · Nature Communications · doi:10.1038/s41467-019-09600-4 · Cited by 61
Whole-genome sequencing reveals rare off-target mutations in CRISPR/Cas9-edited grapevine
Wang, X., Tu, M., Wang, Y., Yin, W., Zhang, Y., Wu, H., Gu, Y., Li, Z., Xi, Z., & Wang, X. (2021) · Horticulture Research · doi:10.1038/s41438-021-00549-4 · Cited by 67
Off‐target assessment of CRISPR ‐ C as9 guiding RNA s in human i PS and mouse ES cells
Tan, E., Li, Y., Velasco‐Herrera, M. D. C., Yusa, K., & Bradley, A. (2014) · genesis · doi:10.1002/dvg.22835 · Cited by 66
CRISPR–Cas9-mediated genome editing and guide RNA design
Wiles, M. V., Qin, W., Cheng, A. W., & Wang, H. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9565-z · Cited by 67
Efficient bi-allelic gene knockout and site-specific knock-in mediated by TALENs in pigs
Yao, J. T., Huang, J., Hai, T., Wang, X., Qin, G., Zhang, H., Wu, R., Cao, C., Xi, J., Yuan, Z., et al. (2014) · Scientific Reports · doi:10.1038/srep06926 · Cited by 63
Mashimo, T. (2013) · Development Growth & Differentiation · doi:10.1111/dgd.12110 · Cited by 70
Fully Automated One-Step Synthesis of Single-Transcript TALEN Pairs Using a Biological Foundry
Chao, R., Liang, J., Tasan, I., Si, T., Ju, L., & Zhao, H. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00293 · Cited by 63
Kirchner, T. W., Niehaus, M., Debener, T., Schenk, M., & Herde, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185429 · Cited by 63
Zhao, C., Zheng, X., Qu, W., Li, G., Li, X., Miao, Y., Han, X., Liu, X., Li, Z., Ma, Y., et al. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21312 · Cited by 62
Deep mutational scanning of S. pyogenes Cas9 reveals important functional domains
Spencer, J. M., & Zhang, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-17081-y · Cited by 65
Genome editing technologies and their applications in crop improvement
Mishra, R., & Zhao, K. (2018) · Plant Biotechnology Reports · doi:10.1007/s11816-018-0472-0 · Cited by 72
Idoko-Akoh, A., Taylor, L., Sang, H., & McGrew, M. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-33244-x · Cited by 62
Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity
Höijer, I., Johansson, J., Gudmundsson, S., Chin, C.-S., Bunikis, I., Häggqvist, S., Emmanouilidou, A., Wilbe, M., den Hoed, M., Bondeson, M.-L., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02206-w · Cited by 65
Gene Editing and Genotoxicity: Targeting the Off-Targets
Blattner, G., Cavazza, A., Thrasher, A. J., & Turchiano, G. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.613252 · Cited by 64
Efficacy and long-term safety of CRISPR/Cas9 genome editing in the SOD1-linked mouse models of ALS
Deng, H., Zhai, H., Shi, Y., Liu, G., Lowry, J., Liu, B., Ryan, É. B., Yan, J., Yang, Y., Zhang, N., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01942-4 · Cited by 66
ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected
Boutin, J., Cappellen, D., Rosier, J., Amintas, S., Dabernat, S., Bedel, A., & Moreau‐Gaudry, F. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0120 · Cited by 59
CRISPR/Cas9-Based Genome Editing and Its Application in Aspergillus Species
Jin, F., Wang, B., Wang, Z., Jin, L., & Han, P. D. (2022) · Journal of Fungi · doi:10.3390/jof8050467 · Cited by 67
CRISPR nuclease off-target activity and mitigation strategies
Wienert, B., & Cromer, M. K. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.1050507 · Cited by 66
Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler, M., & Concordet, J. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.04.008 · Cited by 65
CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential
Blenke, E. O., Evers, M. J. W., Mastrobattista, E., & John van der, O. O. S. T. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.002 · Cited by 63
Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9
Singh, K., Evens, H., Nair, N., Rincón, M. Y., Sarcar, S., Samara-Kuko, E., Chuah, M., & VandenDriessche, T. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.023 · Cited by 63
Delivering on the promise of gene editing for cystic fibrosis
Hodges, C. A., & Conlon, R. A. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.11.005 · Cited by 63
Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9
Choi, G. C. G., Zhou, P., Yuen, C. T. L., Chan, B. K. C., Xu, F., Bao, S., Chu, H. Y., Thean, D., Tan, K., Wong, K. H., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0473-0 · Cited by 63
Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders
Adams, J. W., Cugola, F. R., & Muotri, A. R. (2019) · Physiology · doi:10.1152/physiol.00005.2019 · Cited by 68
Exosome-mediated horizontal gene transfer occurs in double-strand break repair during genome editing
Ono, R., Yasuhiko, Y., Aisaki, K., Kitajima, S., Kanno, J., & Hirabayashi, Y. (2019) · Communications Biology · doi:10.1038/s42003-019-0300-2 · Cited by 65
CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
Ryczek, N., Hryhorowicz, M., Zeyland, J., Lipiński, D., & Słomski, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063196 · Cited by 66
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells
Klermund, J., Rhiel, M., Köcher, T., Chmielewski, K. O., Bischof, J., Andrieux, G., el Gaz, M., Hainzl, S., Boerries, M., Cornu, T. I., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.006 · Cited by 65
Takeuchi, R., Choi, M. Y., & Stoddard, B. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321030111 · Cited by 61
Gene Targeting by Homologous Recombination
Reh, W. A., & Vásquez, K. M. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0005988.pub2 · Cited by 62
Yasue, A., Mitsui, S. N., Watanabe, T., Sakuma, T., Oyadomari, S., Yamamoto, T., Noji, S., Mito, T., & Tanaka, E. I. (2014) · Scientific Reports · doi:10.1038/srep05705 · Cited by 60
Staying on target with CRISPR-Cas
Carroll, D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2684 · Cited by 60
Endonucleases: new tools to edit the mouse genome
Wijshake, T., Baker, D. J., & van de Sluis, B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.020 · Cited by 61
Amini, L., Wagner, D. L., Rössler, U., Zarrinrad, G., Wagner, L. F., Vollmer, T., Wendering, D. J., Kornak, U., Volk, H., Reinke, P., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.09.011 · Cited by 56
Luo, M., Gilbert, B., & Ayliffe, M. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1989-8 · Cited by 60
Porro, F., Bortolussi, G., Barzel, A., Caneva, A. D., Iaconcig, A., Vodret, S., Zentilin, L., Kay, M. A., & Muro, A. F. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707601 · Cited by 62
Microhomology-assisted scarless genome editing in human iPSCs
Kim, S.-I., Matsumoto, T., Kagawa, H., Nakamura, M., Hirohata, R., Ueno, A., Ohishi, M., Sakuma, T., Soga, T., Yamamoto, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03044-y · Cited by 58
Wang, J., Zhang, C., & Feng, B. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15039 · Cited by 61
Huang, W., Zhang, Y., Shen, L., Fang, Q., Liu, Q., Gong, C., Zhang, C., Zhou, Y., Mao, C., Zhu, Y., et al. (2020) · New Phytologist · doi:10.1111/nph.16769 · Cited by 60
Delivery Approaches for Therapeutic Genome Editing and Challenges
Ates, I., Rathbone, T., Stuart, C., Bridges, P. H., & Cottle, R. N. (2020) · Genes · doi:10.3390/genes11101113 · Cited by 63
Cas9 deactivation with photocleavable guide RNAs
Zou, R. S., Liu, Y., Wu, B., & Ha, T. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.02.007 · Cited by 61
Genome-wide detection of CRISPR editing in vivo using GUIDE-tag
Liang, S.-Q., Liu, P., Smith, J. L., Mintzer, E., Maitland, S., Dong, X., Yang, Q., Lee, J., Haynes, C. M., Zhu, L. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28135-9 · Cited by 54
Metadata
- Authors
- Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Joung, J Keith
- Sander, Jeffry D
- Venue
- Nature Biotechnology
- Published
- 2013-06-23
- Volume
- 31
- Issue
- 9
- Pages
- 822-826
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3773023
- OpenAlex
- W2077659966
- Cited by
- 3,292
- References
- 20
- Citations by year
- 2026: 140 · 2025: 181 · 2024: 206 · 2023: 208 · 2022: 246 · 2021: 254 · 2020: 280 · 2019: 274 · 2018: 278 · 2017: 269 · 2016: 314 · 2015: 254 · 2014: 291 · 2013: 90
- FWCI
- 141.80
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Human Genome Research Institute (P50HG005550)
- National Institute of General Medical Sciences (DP1GM105378, R01GM088040)
- National Center for Chronic Disease Prevention and Health Promotion (DP1 GM105378)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, off-target cleavage, RNA-guided nucleases, mismatch tolerance, genome editing, mutagenesis, human cells, off-target sites
- MeSH terms
- Base Sequence, Endonucleases, Genetic Engineering, Humans, Molecular Sequence Data, Mutagenesis, K562 Cells, HEK293 Cells, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
